Literature DB >> 20146027

Incrementally applied multifaceted therapeutic bundles in neuroprotection clinical trials...time for change.

W Andrew Kofke1.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20146027     DOI： 10.1007/s12028-010-9332-7

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN： 1541-6933            Impact factor:   3.210


× No keyword cloud information.
  36 in total

1.  Protective effect of systemic treatment with cyclosporine A after global ischemia in rats.

Authors:  R Sinigaglia-Coimbra; E A Cavalheiro; C Coimbra
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

Review 2.  An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults.

Authors:  John A Bartlett; Michael J Fath; Ralph Demasi; Ashwaq Hermes; Joseph Quinn; Elsa Mondou; Franck Rousseau
Journal:  AIDS       Date:  2006-10-24       Impact factor: 4.177

3.  Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat.

Authors:  Robert Siman; Chen Zhang; Victoria L Roberts; Alex Pitts-Kiefer; Robert W Neumar
Journal:  J Cereb Blood Flow Metab       Date:  2005-11       Impact factor: 6.200

4.  Effectiveness and safety of transcranial laser therapy for acute ischemic stroke.

Authors:  Justin A Zivin; Gregory W Albers; Natan Bornstein; Thomas Chippendale; Bjorn Dahlof; Thomas Devlin; Marc Fisher; Werner Hacke; William Holt; Sanja Ilic; Scott Kasner; Robert Lew; Marshall Nash; Julio Perez; Marilyn Rymer; Peter Schellinger; Dietmar Schneider; Stefan Schwab; Roland Veltkamp; Michael Walker; Jackson Streeter
Journal:  Stroke       Date:  2009-02-20       Impact factor: 7.914

5.  Cerebral norepinephrine depletion enhances recovery after brain ischemia.

Authors:  R Busto; S I Harik; S Yoshida; P Scheinberg; M D Ginsberg
Journal:  Ann Neurol       Date:  1985-09       Impact factor: 10.422

Review 6.  Hypothermia treatment for traumatic brain injury: a systematic review and meta-analysis.

Authors:  Kim Peterson; Susan Carson; Nancy Carney
Journal:  J Neurotrauma       Date:  2008-01       Impact factor: 5.269

7.  Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway.

Authors:  Junichi Hitomi; Dana E Christofferson; Aylwin Ng; Jianhua Yao; Alexei Degterev; Ramnik J Xavier; Junying Yuan
Journal:  Cell       Date:  2008-12-26       Impact factor: 41.582

8.  NXY-059 for acute ischemic stroke.

Authors:  Kennedy R Lees; Justin A Zivin; Tim Ashwood; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; James Grotta; Patrick Lyden; Ashfaq Shuaib; Hans-Göran Hårdemark; Warren W Wasiewski
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

9.  Multimodal neuroprotective therapy with induced hypothermia after ischemic stroke.

Authors:  Thomas M Hemmen; Patrick D Lyden
Journal:  Stroke       Date:  2008-12-08       Impact factor: 7.914

10.  The 2007 Feinberg lecture: a new road map for neuroprotection.

Authors:  Geoffrey A Donnan
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914
View more
  2 in total

Review 1.  Neuroprotective therapies in the NICU in term infants: present and future.

Authors:  Eleanor J Molloy; Mohamed El-Dib; Sandra E Juul; Manon Benders; Fernando Gonzalez; Cynthia Bearer; Yvonne W Wu; Nicola J Robertson; Tim Hurley; Aoife Branagan; C Michael Cotten; Sidhartha Tan; Abbot Laptook; Topun Austin; Khorshid Mohammad; Elizabeth Rogers; Karen Luyt; Sonia Bonifacio; Janet S Soul; Alistair J Gunn
Journal:  Pediatr Res       Date:  2022-10-04       Impact factor: 3.953

2.  Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage.

Authors:  William A Kofke; Yue Ren; John G Augoustides; Hongzhe Li; Katherine Nathanson; Robert Siman; Qing Cheng Meng; Weiming Bu; Sukanya Yandrawatthana; Guy Kositratna; Cecilia Kim; Joseph E Bavaria
Journal:  Front Neurol       Date:  2018-06-26       Impact factor: 4.003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.